2(1H)-ISOQUINOLINEETHANAMINE, 3,4-DIHYDRO-6,7-DIMETHOXY-, 95.0%, 1g

3-Fluoro-3-methylbutan-1-amine hydrochloride, 95%, 100mg

5H-Pyrrolo[2,3-b]pyrazine-7-carboxylic acid, 95.0%, 250mg

Potassium hydrogen sulphate, min. 99%, pa, 1 kg, plastic packaging.

1-(4-Chlorobenzyl)-1H-pyrazole-4-carboxylic acid, 95.0%, 100g

(4-(N-Benzylsulfamoyl)phenyl)boronic acid, 95.0%, 250mg

D-Glucosamic Acid>98.0%(T)5g

(methylamino)(2-thienyl)acetic acid hydrochloride, 95.0%, 10g

1,3-Bis((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one  (Ibrutinib Impurity）, 97%, 50mg

2-(3-(Bromomethyl)-2-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3,5-difluorophenyl)propanoic acid, 97%, 1g

4-Methylnicotinic acid, 97.0%, 10g

Methyl 3,5-difluoro-4-formylbenzoate, 97.0%, 25g